Mesoblast (MESO) Shares Outstanding (2014 - 2025)
Mesoblast (MESO) posted Shares Outstanding (Entity) of $129.0 for Q4 2025, down 100.0% sequentially from $120.8 million in Q2 2025, and up 13.16% YoY from $114.0 in Q4 2024.
Mesoblast (MESO) Shares Outstanding (2014 - 2025) Analysis & Trends
Mesoblast has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $129.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 13.16% year-over-year to $129.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129.0 (up 13.16% YoY) and the FY2025 annual result came in at $120.8 million, up 121999206.06% from the prior year.
- Shares Outstanding (Entity) slipped to $129.0 in Q4 2025 per MESO's latest filing, from $120.8 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $120.8 million in Q2 2025 and troughed at $60.0 in Q1 2021.
- A 5-year average of $8.1 million and a median of $74.0 in 2022 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) slumped 32.94% in 2024, then surged 121999206.06% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $65.0 in 2021, then grew by 13.85% to $74.0 in 2022, then jumped by 129.73% to $170.0 in 2023, then plunged by 32.94% to $114.0 in 2024, then advanced by 13.16% to $129.0 in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $129.0, $120.8 million, and $114.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Jun 30, 2024 | 986.70 Mn |
| Dec 31, 2023 | 851.46 Mn |
| Jun 30, 2023 | 369.52 Mn |
| Mar 31, 2023 | 368.29 Mn |
| Dec 31, 2022 | 368.29 Mn |
| Sep 30, 2022 | 348.04 Mn |
| Jun 30, 2022 | 324.45 Mn |
| Mar 31, 2022 | 324.78 Mn |
| Dec 31, 2021 | 324.05 Mn |
| Sep 30, 2021 | 324.02 Mn |
| Jun 30, 2021 | 302.53 Mn |
| Mar 31, 2021 | 302.22 Mn |
| Dec 31, 2020 | 293.18 Mn |
| Sep 30, 2020 | 291.24 Mn |
| Jun 30, 2020 | 264.41 Mn |
| Mar 31, 2020 | 268.83 Mn |
| Dec 31, 2019 | 267.21 Mn |